Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M75,288Revenue (TTM) $M14,744Net Margin (%)82.4Altman Z-Score1.1
Enterprise Value $M103,026EPS (TTM) $38.4Operating Margin %-17.4Piotroski F-Score8
P/E(ttm)5.9Beneish M-Score-2.0Pre-tax Margin (%)-36.8Higher ROA y-yY
Price/Book1.110-y EBITDA Growth Rate %--Quick Ratio1.2Cash flow > EarningsN
Price/Sales5.65-y EBITDA Growth Rate %3.6Current Ratio1.3Lower Leverage y-yY
Price/Free Cash Flow292y-y EBITDA Growth Rate %-37.7ROA % (ttm)9.1Higher Current Ratio y-yY
Dividend Yield %0.6PEG--ROE % (ttm)15.0Less Shares Outstanding y-yY
Payout Ratio %--Shares Outstanding M336ROIC % (ttm)-1.2Gross Margin Increase y-yY

Gurus Latest Trades with AGN

Number of guru portfolios checked: 68.
Ticker Guru Date Action
Impact Price Range
(Average)*
Current Price Change from Average Comment Current Shares

AGN is held by these investors:



AGN: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Basgoz NesliDirector 2017-05-18Sell1,889$220.451.66view
BISARO PAULDirector 2017-03-02Sell70,000$246.68-9.15view
Basgoz NesliDirector 2016-12-08Sell500$188.7218.75view
SAUNDERS BRENT LCEO and President 2016-11-21Buy5,250$189.1318.49view
Hilado Maria TeresaCFO 2016-11-11Buy1,422$210.646.39view
Basgoz NesliDirector 2016-08-05Sell758$253.02-11.43view
Hilado Maria TeresaCFO 2016-06-02Buy661$241.57-7.23view
Basgoz NesliDirector 2016-05-11Sell459$225.1-0.44view
Basgoz NesliDirector 2015-12-07Sell2,300$312.96-28.39view
BISARO PAULExec Chairman 2015-08-24Buy1,000$297.42-24.65view

Press Releases about AGN :

Quarterly/Annual Reports about AGN:

News about AGN:

Articles On GuruFocus.com
Allergan Announces Early Tender Results and Upsizing of Tender Offers by Certain Subsidiaries May 24 2017 
Kristin Chenoweth Kicks Off 'Less Red, More You' Campaign To Launch RHOFADE™ (Oxymetazoline HCL) C May 23 2017 
Allergan Announces Pricing of Public Offering of Senior Notes to Refinance Existing Debt May 23 2017 
Allergan Announces Commencement of Proposed Public Offering of Senior Notes to Refinance Existing De May 23 2017 
NWQ Managers Sells Pfizer, Viacom, Edison May 22 2017 
Seth Klarman Adds Some Interesting New Positions May 16 2017 
Allergan's Eyepowerment™ Campaign Releases Survey Revealing the Importance of Eye Language and the May 16 2017 
Allergan to Present at the Bernstein Strategic Decisions Conference May 15 2017 
Seth Klarman Backs Out of Innoviva Days After Activist Stakeholder Defeated May 10 2017 
Allergan Announces Tender Offers by Certain Subsidiaries May 10 2017 

More From Other Websites
Shark Bites: Focus on the 'Little Picture' May 24 2017
Allergan Announces Early Tender Results and Upsizing of Tender Offers by Certain Subsidiaries May 24 2017
Kristin Chenoweth Kicks Off 'Less Red, More You' Campaign To Launch RHOFADE™ (Oxymetazoline HCL)... May 23 2017
Allergan Announces Pricing of Public Offering of Senior Notes to Refinance Existing Debt May 23 2017
The biggest CEO pay raises and pay cuts of 2016 May 23 2017
Has Allergan's Pullback Run Its Course? May 23 2017
Allergan Funding SCS -- Moody's assigns Baa3 to Allergan's euro notes; stable outlook May 23 2017
These Big Drug Stocks May Cure the Trump Blues May 23 2017
Allergan Announces Commencement of Proposed Public Offering of Senior Notes to Refinance Existing... May 23 2017
3 Drug Stocks Billionaire Money Managers Dumped Big-Time in the First Quarter May 22 2017
European stocks edge higher as U.S. political commotion subsides May 22 2017
Valeant Pharmaceuticals: Intrigued…Really? May 19 2017
Valeant (VRX) Decides to Extend Stay on Xifaxan's ANDA May 19 2017
Allergan's Irritable Bowel Drug Viberzi Approved in Canada May 17 2017
Cardiome (CRME) Q1 Loss Wider Than Expected, Sales Miss May 17 2017
Valeant and Actavis agree to stay litigation relating to Valeant's top-selling drug Xifaxan May 17 2017
Is Editas Facing a New Reality in CRISPR Land? May 16 2017
Cramer: Carl Icahn Was Right to Sell Apple at $95 May 16 2017
Biotech Movers: Akebia, Editas, Novavax May 16 2017
Allergan's Eyepowerment™ Campaign Releases Survey Revealing the Importance of Eye Language and the... May 16 2017

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}